Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![bill_us Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::525427904.png) xTrade ⚛ [@bill_us](/creator/twitter/bill_us) on x 2331 followers
Created: 2025-07-23 12:07:24 UTC

$IOVA SI >30%. With $REPL down XX% yesterday due to the CRL, leaving $IOVA as the only drug approved without future competition. 
Fundamentally and technically, $IOVA is poised to make a huge rally. Its 52-week high was $XX. 
With short squeeze on, $IOVA will move past $XX by EOY


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947991937027350876/c:line.svg)

**Related Topics**
[repl](/topic/repl)
[stocks](/topic/stocks)
[approved](/topic/approved)
[$repl](/topic/$repl)
[$iova](/topic/$iova)

[Post Link](https://x.com/bill_us/status/1947991937027350876)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

bill_us Avatar xTrade ⚛ @bill_us on x 2331 followers Created: 2025-07-23 12:07:24 UTC

$IOVA SI >30%. With $REPL down XX% yesterday due to the CRL, leaving $IOVA as the only drug approved without future competition. Fundamentally and technically, $IOVA is poised to make a huge rally. Its 52-week high was $XX. With short squeeze on, $IOVA will move past $XX by EOY

XXXXX engagements

Engagements Line Chart

Related Topics repl stocks approved $repl $iova

Post Link

post/tweet::1947991937027350876
/post/tweet::1947991937027350876